AA by nature is often a chronic and relapsing disease (3, 17, 78, 215), and a shifting repertoire of T-cell specificities to an ever-expanding repertoire of follicular autoantigens that emerge from repeated cycles of HF tissue disruption will further dictate the development of therapeutics targeting pathways beyond JAK/STAT signaling. The gene discussed is SOAT1; the disease is hydrops fetalis.